Allergan Announces Quarterly Conference Call

Before you go, we thought you'd like these...
Before you go close icon

Allergan Announces Quarterly Conference Call

IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc. (NYS: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer, discuss the Company's second quarter 2013 results on Wednesday, July 31, 2013. The live Webcast can be accessed through the Allergan Web site,, beginning at 8:00 a.m. Pacific Time. A replay of the discussion will be available shortly after the call and can be accessed through, or by dialing 1-800-839-2234 for domestic locations or 1-402-998-1175 for international locations. A passcode will not be required. The replay will be available for one week following the live call.

It is Allergan's policy to comply fully with Regulation FD. Therefore, Allergan intends to utilize this Webcast event to discuss financially oriented goals and objectives and to disclose material Company and industry-based topics in an open manner. Allergan does not plan to report or comment on its progress during the current fiscal quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to Allergan. During a quarter, Allergan's commentary will be limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial. Allergan will make no comments with respect to market rumors or speculation.

Allergan, Inc.
Jim Hindman
Joann Bradley
David Nakasone

KEYWORDS:   United States  North America  California


The article Allergan Announces Quarterly Conference Call originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

People are Reading